Nothing Special   »   [go: up one dir, main page]

Battaglia et al., 2006 - Google Patents

Induction of tolerance in type 1 diabetes via both CD4+ CD25+ T regulatory cells and T regulatory type 1 cells

Battaglia et al., 2006

View PDF
Document ID
4333735589749345915
Author
Battaglia M
Stabilini A
Draghici E
Migliavacca B
Gregori S
Bonifacio E
Roncarolo M
Publication year
Publication venue
Diabetes

External Links

Snippet

Success in developing novel therapies to recommence self-tolerance in autoimmunity depends on the induction of T regulatory (Tr) cells. Here, we report that rapamycin combined with interleukin (IL)-10 efficiently blocks type 1 diabetes development and induces long-term …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Similar Documents

Publication Publication Date Title
Battaglia et al. Induction of tolerance in type 1 diabetes via both CD4+ CD25+ T regulatory cells and T regulatory type 1 cells
Romano et al. Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity
Maggi et al. Thymic regulatory T cells
Battaglia et al. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance
Taylor et al. L-Selectinhi but not the L-selectinlo CD4+ 25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection
Chen et al. IL-10 and TGF-β induce alloreactive CD4+ CD25–T cells to acquire regulatory cell function
Selck et al. Antigen-specific regulatory T cell therapy in autoimmune diseases and transplantation
Bigenzahn et al. The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade
Lepault et al. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice
Blazar et al. Rapamycin inhibits the generation of graft-versus-host disease-and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines
Bassi et al. Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes
Xystrakis et al. Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation
Madec et al. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells
Nguyen et al. In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation
Li et al. Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance
Habicht et al. A link between PDL1 and T regulatory cells in fetomaternal tolerance
Lourenço et al. Natural regulatory T cells in autoimmunity
Muriglan et al. GITR activation induces an opposite effect on alloreactive CD4+ and CD8+ T cells in graft-versus-host disease
JP4628792B2 (en) Rapamycin and IL-10 for treatment of immune diseases
Charbonnier et al. Adoptive transfer of IL-10-secreting CD4+ CD49b+ regulatory T cells suppresses ongoing arthritis
Gorantla et al. T regulatory cells and transplantation tolerance
Huang et al. IL‐10 producing type 2 innate lymphoid cells prolong islet allograft survival
Issa et al. Translating tolerogenic therapies to the clinic–where do we stand?
Zhang et al. Adoptive cell therapy using antigen-specific CD4− CD8− T regulatory cells to prevent autoimmune diabetes and promote islet allograft survival in NOD mice
Lundsgaard et al. In vivo control of diabetogenic T-cells by regulatory CD4+ CD25+ T-cells expressing Foxp3